The Effect of Pneumoperitoneum (Raised Pressure in the Peritoneal Cavity) During Robotic Kidney/Prostate Cancer Surgery.
Primary Purpose
Acute Kidney Injury, Pneumoperitoneum, Kidney
Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Low intra-abdominal pressure
High (standard) intra-abdominal pressure
Sponsored by
About this trial
This is an interventional prevention trial for Acute Kidney Injury focused on measuring Quality of recovery, Surgical rating scale, intra-abdominal pressure, kidney injury biomarkers
Eligibility Criteria
Inclusion Criteria:
- Patients diagnosed with kidney/prostate cancer at the department of Urology, Aalborg University Hospital, who are offered radical nephrectomy/prostatectomy.
- Speaks and understands Danish
Exclusion Criteria:
- Patient diagnosed with kidney cancer but can be treated with partial nephrectomy.
- Patients with severe to end stage chronic kidney disease (CKD stage 4-5)
- Inability to understand or comply with instructions.
Withdrawal Criteria:
- Inability to complete the surgery without raising the pneumoperitoneum for low pneumoperitoneum arm.
- Complications that require re-operation which can change the quality of recovery of primary operation.
Sites / Locations
- Aalborg university hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Low Intra-abdominal pressure
High (standard) intra-abdominal pressure
Arm Description
Intra-abdominal pressure will be set at 7 mm Hg during the procedure.
Intra-abdominal pressure will be set at 12 mm Hg during the procedure.
Outcomes
Primary Outcome Measures
Quality of recovery
Changes in Quality of recovery assessed by QoR-15 Questionaire from pre-operative to day 30 post-operative level. Participiants fill in quistionaire pre-operatively, day 1,3,14,30
Risk Of Acute kidney injury (AKI)
post-operative renal function and risk for AKI evaluated by u-NGAL
Surgical rating scale
assessed 3 times during surgery. 1st during mobilization of bowel, then during renal vessels dissection, and last time during removing and insertion of kidney in the endobag.
Secondary Outcome Measures
post-operative use of painkillers
All post-operative painkiller registered and converted to morphine using Morphine Milligram Equivalent (MME)
Intra-operative urine output
Duration of operation in minutes
Intra-operative bleeding in ml
u- KIM-1 level
Kidney injury molecule in urine
u-NGAL
Neutrophil gelatinase-associated lipocalin in urine
u- KIM-1 level
Kidney injury molecule in urine
S.creatinine, and eGFR
Kidney injury marker
S.creatinine and eGFR
Kidney injury marker
S.creatinine and eGFR
Kidney injury marker
Other Kidney injury markers, include; TFF,VEGF, Osteoactivin, Clusterin, and Calbindin
Kindey injury markers
Other Kidney injury markers, include; TFF,VEGF, Osteoactivin, Clusterin, and Calbindin
Kidney injury markers
Full Information
NCT ID
NCT04755452
First Posted
February 6, 2021
Last Updated
June 18, 2023
Sponsor
Aalborg University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT04755452
Brief Title
The Effect of Pneumoperitoneum (Raised Pressure in the Peritoneal Cavity) During Robotic Kidney/Prostate Cancer Surgery.
Official Title
The Effect of Pneumoperitoneum During Robot Assisted Laparoscopic Renal/ Prostatic Cancer Surgery - a Randomized Clinical Study Investigating Patient and Surgeon Outcome.
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Completed
Study Start Date
December 23, 2020 (Actual)
Primary Completion Date
February 28, 2022 (Actual)
Study Completion Date
February 28, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Aalborg University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Within all the surgical specialties, major surgeries are performed whenever possible, as minimally invasive procedures to reduce blood loss, reduce pain and discomfort after surgery, avoid major scars, provide a faster recovery and thus shorter hospital stay. Such minimally invasive procedures in urinary tract surgeries are often performed as laparoscopic or robotic surgeries where CO2 (carbon dioxide) is insufflated into the abdominal cavity to create a working space for the surgeon's instruments. That high pressure created in the abdominal cavity (pneumoperitoneum) to create a workspace for the surgeon start a series of physiological changes in the heart, lung and kidney.
Today, most laparoscopic, and robotic operations are performed with pneumoperitoneum of approximately 12-15 mm Hg, despite the fact that international guidelines recommend the use of the lowest intra-abdominal pressure (IAP) possible allowing adequate exposure of the operative field rather than using a routine pressure level.
Investigator will conduct a randomized double-blind study involving 120 patients (2 groups of 60). The first group will be operated with standard pressure in the abdominal cavity 12-15 mm Hg (high IAP), patients in the second group will be operated on with a reduced pressure of ≈ 7 mmHg (low IAP).
Investigator would like to assess the practical feasibility of operating under low IAP. Quality of recovery of patients in relation to both physical and mental status, and post-operative use of pain killer will be also investigated using a validated questionnaire . Finally, Invistigator will examine the impact of IAP on post-operative renal function, and risk of kidney injury.
Hypothesis is carrying out laparoscopic/robotic surgeries under low IAP can optimize the post-operative quality of recovery, decrease pain and use of pain killer, improve post-operative renal function, and decrease risk for kidney injury. On the other hand low IAP can risk overview for surgeon, make workspace smaller and raise risk of bleeding.
Detailed Description
A total of 120 patients between the ages of 18 and 80 years who were scheduled for elective robotic radical nephrectomy/ prostatectomy will included in the study. This is randomized controlled double-blind clinical trial.
A standard anesthesia protocol will be used in both groups. Bladder catheter inserted by the OP-nurse. After ports installment under IAP of 7 mm Hg, the surgeon leaves the operation field and sits at a surgical console. The ground nurse opens the sealed letter which indicated the pressure for operation (electronic randomization was previously performed by investigator using https://www.graphpad.com/quickcalcs/index.cfm) The required IAP sets by the ground nurse before the surgery started. Assistants are not blinded in the study, but the surgeon is. Intra-abdominal pressure will be maintained at 7 mmHg in Group Low IAP and at 12 mmHg in Group High IAP throughout the surgery. If under operation the surgeon required to raise the IAP because of bad views, or bleeding, he/she can always ask the ground nurse to raise the pressure by 2- or 3-mm Hg at a time until surgeon obtain the preferred view. This involved both groups. Patient will not be excluded from study if pressure increased, but the duration of raised IAP will be registered.
During the operation, the surgical working space will be evaluated by surgeon using an adopted version of SRS (Surgical rating scale). 1st time during mobilization of bowel, 2nd time during renal vascular dissection, and last time when surgeon remove the kidney and set it in the Endobag.
All patients asked to register their 24-hour urine production before the operation day. Intra-operative urine output will be also registered. 10 ml urine will be collected 3 times in order to investigate the risk of Acute Kidney Injury (AKI) by kidney injury biomarker (u-NGAL, og KIM-1). Pre-operatively during urinary catheter placement, 2-hour post-operatively, and 24 hours after operation. Urine samples collected and stored in -80 C for later analyses.
Investigator will test the quality of recovery using a validated Quality of recovery-15 (QoR-15) questionnaire before the surgery and at day 1,3,14,30 post-op.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Kidney Injury, Pneumoperitoneum, Kidney
Keywords
Quality of recovery, Surgical rating scale, intra-abdominal pressure, kidney injury biomarkers
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
100 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Low Intra-abdominal pressure
Arm Type
Experimental
Arm Description
Intra-abdominal pressure will be set at 7 mm Hg during the procedure.
Arm Title
High (standard) intra-abdominal pressure
Arm Type
Active Comparator
Arm Description
Intra-abdominal pressure will be set at 12 mm Hg during the procedure.
Intervention Type
Procedure
Intervention Name(s)
Low intra-abdominal pressure
Intervention Description
7 mm Hg pneumoperitoneum during robot-assisted laparoscopic surgery
Intervention Type
Procedure
Intervention Name(s)
High (standard) intra-abdominal pressure
Intervention Description
12 mm Hg pneumoperitoneum during robot-assisted laparoscopic surgery
Primary Outcome Measure Information:
Title
Quality of recovery
Description
Changes in Quality of recovery assessed by QoR-15 Questionaire from pre-operative to day 30 post-operative level. Participiants fill in quistionaire pre-operatively, day 1,3,14,30
Time Frame
fulled by the patient pre-operatively and then on post-operative day 1,3,14 and 30
Title
Risk Of Acute kidney injury (AKI)
Description
post-operative renal function and risk for AKI evaluated by u-NGAL
Time Frame
24 hours after surgery
Title
Surgical rating scale
Description
assessed 3 times during surgery. 1st during mobilization of bowel, then during renal vessels dissection, and last time during removing and insertion of kidney in the endobag.
Time Frame
intra-operative
Secondary Outcome Measure Information:
Title
post-operative use of painkillers
Description
All post-operative painkiller registered and converted to morphine using Morphine Milligram Equivalent (MME)
Time Frame
24 hours after surgery
Title
Intra-operative urine output
Time Frame
intra-operative
Title
Duration of operation in minutes
Time Frame
intra-operative
Title
Intra-operative bleeding in ml
Time Frame
intra-operative
Title
u- KIM-1 level
Description
Kidney injury molecule in urine
Time Frame
Before surgery
Title
u-NGAL
Description
Neutrophil gelatinase-associated lipocalin in urine
Time Frame
24 hours after surgery
Title
u- KIM-1 level
Description
Kidney injury molecule in urine
Time Frame
24 hours after surgery
Title
S.creatinine, and eGFR
Description
Kidney injury marker
Time Frame
24 hours after surgery
Title
S.creatinine and eGFR
Description
Kidney injury marker
Time Frame
10 days after surgery
Title
S.creatinine and eGFR
Description
Kidney injury marker
Time Frame
21 days after surgery
Title
Other Kidney injury markers, include; TFF,VEGF, Osteoactivin, Clusterin, and Calbindin
Description
Kindey injury markers
Time Frame
Before surgery
Title
Other Kidney injury markers, include; TFF,VEGF, Osteoactivin, Clusterin, and Calbindin
Description
Kidney injury markers
Time Frame
24 hours after surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients diagnosed with kidney/prostate cancer at the department of Urology, Aalborg University Hospital, who are offered radical nephrectomy/prostatectomy.
Speaks and understands Danish
Exclusion Criteria:
Patient diagnosed with kidney cancer but can be treated with partial nephrectomy.
Patients with severe to end stage chronic kidney disease (CKD stage 4-5)
Inability to understand or comply with instructions.
Withdrawal Criteria:
Inability to complete the surgery without raising the pneumoperitoneum for low pneumoperitoneum arm.
Complications that require re-operation which can change the quality of recovery of primary operation.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hayder Al-husseinawi, M.D.
Organizational Affiliation
Aalborg University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Aalborg university hospital
City
Aalborg
State/Province
North Jutland
ZIP/Postal Code
9000
Country
Denmark
12. IPD Sharing Statement
Learn more about this trial
The Effect of Pneumoperitoneum (Raised Pressure in the Peritoneal Cavity) During Robotic Kidney/Prostate Cancer Surgery.
We'll reach out to this number within 24 hrs